The Wrong Fix

Most business declines do not begin with catastrophe. They begin with a wobble.

A soft quarter. A missed forecast. A slight loss of momentum. A gap is discussed in a meeting, and suddenly the room is less interested in understanding the problem than in doing something about it. Quickly.

That is where the danger starts.

The core argument of this article, drawn from years of practitioner experience and reflection, is simple: what kills many businesses is often not the initial problem, but the inadequate reaction to it.

In companies, this reaction usually arrives disguised as prudence. A set of measures is launched to “protect the quarter,” “support sales,” “optimize spend,” or “improve efficiency.” These phrases have a magical quality: they make almost any act of panic sound like management.

You see this pattern especially clearly in brand management, where a wobble in performance is often followed by promotions, cuts to long-term marketing support, frantic ‘lower-funnel’ sales stimulation, or quality-damaging cost reductions. Taken one by one, these decisions are easy to defend. Repeated over time, they often do more damage than the original problem. That is the essence of toxic defense: corrective moves that stabilize the present while quietly poisoning the future.

A useful analogy is 1929. The Wall Street crash was brutal, but what turned a financial shock into a deeper, longer, global depression was not the crash itself. It was the response that followed.

Policymakers, bankers, and business leaders did not yet have the conceptual tools later associated with Keynesian demand management, Milton Friedman and Anna Schwartz’s analysis of monetary collapse, or Galbraith’s broader interpretations of instability and speculation. In other words, the ‘mental software’ was missing. So many serious people reached for remedies that sounded sober, moral, and disciplined at the time: cutting spending, raising taxes, and accepting economic pain as a necessary purge rather than something to fight aggressively and proactively.

With the wrong diagnosis, intelligent people did not simply fail to solve the problem. They helped intensify it. Businesses often behave the same way. The first setback is frequently survivable. The treatment plan is what turns it into a crisis.

The second analogy is older, bloodier, and in some ways even more useful. For centuries, bloodletting was practiced by intelligent physicians using the best logic available to them. A feverish patient appeared overheated, congested, out of balance. Removing blood seemed rational. It was accepted medicine. It gave the doctor something concrete to do. It reassured everyone in the room that action was being taken. And it was not some fringe superstition. It was mainstream practice, used on patients high and low, and likely contributed to the deaths of famous figures such as George Washington.

The problem, of course, was that in many cases the diagnosis was wrong. Doctors did not yet understand viruses, infection, or the real mechanisms driving illness. So the treatment weakened the patient further. Sometimes it helped kill him.

Many corporate responses work in exactly this way. They sound reasonable. They are satisfying because they give people the comforting impression that they are doing something. But when they are based on the wrong understanding of the problem, they do not cure. They deplete.

Why Toxic Fixes Win?

Why do businesses keep choosing these bad remedies? Usually for three very human reasons.

First, they sound logical. They are acceptable. “We need to protect profit” is the kind of sentence nobody objects to in a meeting.

Second, they are easier to implement than carrying out a real diagnosis or doing the slower, harder work of rebuilding desirability or repairing pack-price architecture. It is far simpler to cut something, discount something, push something, or reclassify something than to admit the business does not yet understand what is happening.

Third, they are fast. And speed is deeply comforting to organizations under pressure. It creates visible movement, which is often mistaken for competence. Businesses love activity because activity photographs well in PowerPoint.

Some toxic fixes also win because they are simply more fun. Changing a positioning, or rewriting a brand signature feels creative, important, and glamorous compared with the slower, duller work of fixing pricing, product quality, or distribution. These moves are not just easier to sell internally. They are more enjoyable to work on.

That is why toxic defense thrives. It offers a plausible narrative, a plan of action, and the emotional relief of motion. What it does not reliably offer is recovery.

What Toxic Defense Looks Like

Take promotions. They can produce a short-term lift in volume and make everyone feel briefly less miserable. But their side effects are ugly. Consumers learn to wait for the next deal. Pricing power weakens. Quality signals erode. The brand begins to lose control of its own price ladder. And because promotions mostly harvest existing demand rather than build it, the pattern starts to resemble dependence. The first hit looks tactical. The tenth looks needy.

Or take marketing cuts. These are among the most common forms of corporate self-harm because the initial optics are wonderful. Cutting marketing feels fantastic at first: profits go up, CFO smiles, nothing collapses. People even say things like, “We’ve probably just cut the fat,” usually while cutting muscle. But brands do not disappear overnight. They erode. Salience fades, preference weakens, pricing power slips, and then the organization reaches for still more short-term stimulation to compensate. What felt like discipline turns out to be a slow-release poison.

A more sophisticated version of the same mistake is the shift from long-term brand investment to short-term activation while pretending the overall budget is “stable.” This is one of corporate life’s finer frauds. On paper, marketing support has not been cut. In reality, the money has moved from future demand creation to immediate sales stimulation, trade pressure, incentives, and lower-funnel activity. The quarter looks safer. The brand gets smaller.

This is where Les Binet and Peter Field matter. They are among the most influential effectiveness researchers in modern marketing, known for their work on the IPA Databank, one of the richest sources of advertising campaign evidence. Their report The Long and the Short of It became a landmark because it gave marketers hard evidence for something many sensed but struggled to prove in the boardroom: short-term activation and long-term brand building do different jobs, over different time horizons, and businesses damage themselves when they raid one to fund the other.

Their argument was not that activation is bad. Quite the opposite. Activation is essential, but it mainly harvests demand that already exists. Brand building works more slowly, but it supports broad demand, pricing power, market share growth, and profitability over time. That is why their famous 60:40 guidance mattered so much. It gave companies a practical way to think about balance – not as ideology, but as effectiveness.

So when a company cuts equity-building spend to fund more short-term commercial pressure, it is not making marketing more accountable. It is mortgaging future demand to feel better this quarter. Trade spend buys you a moment. Brand investment improves the odds that people will choose you later, even when nothing is on deal. One helps close the month. The other helps deserve the next few years.

Then there are cost reductions that damage the product itself while being presented as operational excellence. Sometimes cost work is smart. Waste is removed, engineering improves, consumers do not lose anything that matters. Fine. But under pressure, many businesses reach for the fantasy version: cheaper ingredients, thinner materials, downgraded inputs, compromised experience, and a quiet hope that nobody will notice. They often do notice, though not always immediately. The brand eventually pays. There are few phrases in business more pernicious than “technically, the specs are the same.”

An even more dangerous move is to change the positioning, brand signature, or target consumer when performance starts to wobble. Under pressure, teams decide the brand needs a new promise, a fresher tone, or a younger audience. It feels strategic, visible, and far easier than fixing the harder mechanics of desirability, pricing, or distribution. But these moves often blur the brand’s role, weaken its distinctive cues, and alienate the consumers who were still buying it. What is framed as rejuvenation often turns out to be confusion.

Finally, there is pack-price architecture drift: a wonderfully dry term for a very expensive mess. Strong brands have a pricing system. Formats have roles, and price points in relation to one another and to competitors. When brand performance wobbles or costs rise, it becomes very tempting to change the price of certain formats in isolation, just to protect margin or recover volume. That is often where the trouble begins. When each price change, new format, or margin-protecting adjustment is made one by one, without regard for the whole, the system starts to deform. Soon the ladder is no longer a ladder. It is modern art. Value perception blurs. Premium mix quietly dies. Retailers begin to suspect, correctly, that no one is steering the ship. And this kind of structural damage is painful to reverse.

The Harder Truth

The broader lesson is uncomfortable. In business, as in medicine and economics, the danger is not merely inaction. The danger is wrong action administered with confidence. Especially wrong action that sounds prudent, travels well in PowerPoint, and allows everyone involved to feel managerial rather than frightened.

That is why businesses so often choose the wrong fix. Not because executives are stupid. Usually they are smart, diligent, well-intentioned, operating under pressure with

incomplete diagnosis and a strong institutional preference for remedies that are acceptable, easy, and fast. But acceptable is not the same as adequate. Easy is not the same as savvy. And fast is not the same as effective.

When a business starts wobbling, the most important question is not, “What can we do immediately?” It is, “What is actually going wrong, and which of our favorite remedies are likely to make it worse?”

That is the less comforting question. It is also the one that saves brands.

Because in the end, many businesses are not destroyed by the first fever.

They are destroyed by the bloodletting.